Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
A double-blind, U.S. and Australian Phase III lot-to-lot consistency trial in about 3,000 healthy adults showed that single doses of oral PXVX0200 met the primary endpoint of consistency of manufactur...
